The high-risk patients identified with our score were characterized by the genes involved in several major pathways implicated in MM pathophysiology, including interferon response, cell proliferation, hypoxia, IL-6 signaling pathway, stem cell genes, MYC, and epigenetic deregulation (Figure 2A). Here, MYC is linked to Miyoshi myopathy.